HK StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

TENNOR THERAP-B

136.400

-13.400-8.95%

Volume:176.15K

Turnover:25.78M

Market Cap:7.14B

PE:-35.47

High:158.000

Open:148.600

Low:132.300

Close:149.800

52wk High:287.000

52wk Low:132.300

Shares:52.33M

HK Float Shares:52.33M

Volume Ratio:1.44

T/O Rate:0.34%

Dividend:- -

Dividend Rate:- -

EPS(LYR):-3.845

ROE:--

ROA:-41.38%

PB:9.33

PE(LYR):-35.47

PS:- -

Loading ...

Overview Company News Filings

Tennor Therapeutics Reports Positive Phase Iia Poc Data for Rifaquizinone (Tnp-2092), the First Non-Surgical Therapy Candidate for Periprosthetic Joint Infection

THOMSON REUTERS

Tennor Therapy-B Surges on Stock Connect Inclusion and Positive Clinical Data

Tennor Therap-B Surges 15% on Positive Phase IIa Data and New Drug Approval

Tennor Therapeutics Wins China NMPA Clearance for TNP-2092 Phase IIb PJI Trial

TenNor Therapeutics Shows Stable Share Structure in August 2026 Filing

Bulletin Express

TenNor Therapeutics 1H FY26 Loss Narrows 17.81% to RMB 64.25 Million

Danuo Pharma-B Added to Hang Seng Composite Index, Paving Way for Stock Connect Inclusion

TenNor Therapeutics Schedules Board Meeting to Review Interim Results, Consider Dividend

TenNor Therapeutics Reports Stable Share Base and Confirms Public Float Compliance for June 2026

Bulletin Express

TenNor Therapeutics secures 100% shareholder backing for all six AGM resolutions

Bulletin Express

Tennor Therapeutics Holds Annual Shareholders’ Meeting

TenNor Therapeutics issues notice for 2025 Annual Shareholders’ Meeting

Bulletin Express

TenNor Therapeutics Releases Proxy Details for 29 June 2026 Annual Shareholders’ Meeting

Bulletin Express

TenNor Therapeutics announces annual shareholders meeting

TenNor Therapeutics to Withhold 2025 Dividends and Re-Appoint PwC as 2026 Auditor

Bulletin Express

TenNor Therapeutics Publishes Revised Articles, Detailing Share Capital, Governance Structure and Dividend Policy

Bulletin Express

TenNor Therapeutics amends Articles post-IPO, skips FY2025 dividend, reshuffles remuneration committee

Bulletin Express

TenNor Therapeutics files list of directors with Hong Kong Stock Exchange

TENNOR THERAP-B Appoints Dr. Song Gaoguang to Compensation and Assessment Committee

TenNor Therapeutics issues shareholder letter on electronic dissemination of corporate communications

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.atigrzen.com/stock/06872/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"06872","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"06872\",,,,,undefined,":{"symbol":"06872","market":"HK","secType":"STK","nameCN":"TENNOR THERAP-B","latestPrice":136.4,"timestamp":1789027722331,"preClose":149.8,"halted":0,"volume":176150,"delay":0,"changeRate":-0.08945260347129509,"floatShares":52328926,"shares":52328926,"eps":-3.845134,"marketStatus":"Not Yet Opened","change":-13.4,"latestTime":"09-10 16:08:42","open":148.6,"high":158,"low":132.3,"amount":25781120,"amplitude":0.171562,"askPrice":136.4,"askSize":300,"bidPrice":135.1,"bidSize":50,"shortable":0,"etf":0,"ttmEps":-3.065,"tradingStatus":0,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1789090200000},"marketStatusCode":0,"adr":0,"listingDate":1779379200000,"exchange":"SEHK","adjPreClose":149.8,"openAndCloseTimeList":[[1789003800000,1789012800000],[1789016400000,1789027200000]],"volumeRatio":1.443169,"lotSize":50,"spreadScale":0,"tradeCurrency":"HKD"},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"06872\",,,,,undefined,":{"symbol":"06872","floatShares":52328926,"roa":"-41.38%","roe":"--","lyrEps":-3.845134,"volumeRatio":1.443169,"shares":52328926,"dividePrice":0,"high":158,"amplitude":0.171562,"preClose":149.8,"low":132.3,"week52Low":132.3,"pbRate":"9.33","week52High":287,"institutionHeld":0,"latestPrice":136.4,"committee":-0.714286,"eps":-3.845134,"divideRate":0,"volume":176150,"delay":0,"ttmEps":-3.065,"open":148.6,"prevYearClose":75.7,"prevWeekClose":168,"prevMonthClose":188.2,"prevQuarterClose":218.6,"fiveDayClose":173.8,"twentyDayClose":199.5,"sixtyDayClose":254},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/06872\",params:#limit:5,,,undefined,":[{"date":"2026-08-26","symbol":"06872","type":"earning","reportTimeType":"","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1787707800000,"name":null,"time":"","dateTimestamp":1787673600000,"actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"06872\",market:\"HK\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"06872\",market:\"HK\",delay:false,,,undefined,":{},"@#url:\"https://hq.skytigris.cn/hkstock/value_analysis/stock/06872\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"06872","date":"2026-09-09","current":-44.502447,"percent":0.96,"low":-79.827178,"twenty":-63.218073,"median":-58.733667,"eighty":-53.687748,"high":-22.197537,"avg":-59.237919,"sd":9.052548,"marketCap":7838873114},"quantilePoints":[{"date":"2026-05-22","current":-61.8716,"twenty":-53.936788,"median":-42.034569,"eighty":-30.13235,"marketCap":10919983436},{"date":"2026-05-29","current":-59.494815,"twenty":-62.838158,"median":-61.618293,"eighty":-59.494815,"marketCap":10537007713},{"date":"2026-06-05","current":-62.851725,"twenty":-62.838158,"median":-60.050534,"eighty":-58.89743,"marketCap":11147698730},{"date":"2026-06-12","current":-76.559316,"twenty":-67.151261,"median":-61.677494,"eighty":-59.494815,"marketCap":13569761407},{"date":"2026-06-18","current":-77.133424,"twenty":-72.687664,"median":-62.661499,"eighty":-59.556904,"marketCap":13704320444},{"date":"2026-06-26","current":-70.955051,"twenty":-75.200431,"median":-67.151261,"eighty":-59.954912,"marketCap":12545042582},{"date":"2026-07-03","current":-58.617008,"twenty":-74.357411,"median":-63.947365,"eighty":-59.541382,"marketCap":10371396590},{"date":"2026-07-10","current":-60.15333,"twenty":-73.973221,"median":-62.661499,"eighty":-59.255861,"marketCap":10630163970},{"date":"2026-07-17","current":-55.825344,"twenty":-72.988779,"median":-61.483388,"eighty":-58.84852,"marketCap":9900439958},{"date":"2026-07-24","current":-49.131605,"twenty":-71.514675,"median":-60.732749,"eighty":-58.099276,"marketCap":8715285358},{"date":"2026-07-31","current":-46.679708,"twenty":-70.790774,"median":-60.234228,"eighty":-52.553459,"marketCap":8296082202},{"date":"2026-08-07","current":-55.366509,"twenty":-69.892278,"median":-60.050534,"eighty":-50.857587,"marketCap":9859037178},{"date":"2026-08-14","current":-57.79283,"twenty":-68.864339,"median":-59.266767,"eighty":-52.426498,"marketCap":10304117071},{"date":"2026-08-21","current":-57.375761,"twenty":-68.134271,"median":-58.89743,"eighty":-52.755376,"marketCap":10252363595},{"date":"2026-08-28","current":-60.609482,"twenty":-65.869703,"median":-58.836292,"eighty":-53.963985,"marketCap":9848303873},{"date":"2026-09-04","current":-54.082397,"twenty":-63.655648,"median":-58.89743,"eighty":-54.200774,"marketCap":8791259568},{"date":"2026-09-09","current":-48.146411,"twenty":-63.218073,"median":-58.733667,"eighty":-53.687748,"marketCap":7838873114}],"updateTime":1789051729652},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"06872\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2666598860","title":"Tennor Therapeutics Reports Positive Phase Iia Poc Data for Rifaquizinone (Tnp-2092), the First Non-Surgical Therapy Candidate for Periprosthetic Joint Infection","url":"https://stock-news.laohu8.com/highlight/detail?id=2666598860","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666598860?lang=en_us&edition=fundamental","pubTime":"2026-09-10 19:30","pubTimestamp":1789039801,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260910:nTUA8RLFX0:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK1161","06872"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1193471207","title":"Tennor Therapy-B Surges on Stock Connect Inclusion and Positive Clinical Data","url":"https://stock-news.laohu8.com/highlight/detail?id=1193471207","media":"Stock News","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1193471207?lang=en_us&edition=fundamental","pubTime":"2026-09-08 15:12","pubTimestamp":1788851535,"startTime":"0","endTime":"0","summary":"Shares of Tennor Therapy-B (06872) advanced more than 7% in early trading, continuing a volatile week for the biopharmaceutical firm. The stock had previously spiked over 15% in the prior session...","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["VXUS","06872","KCAI","BK4585","FLHK","BK1161","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1132266264","title":"Tennor Therap-B Surges 15% on Positive Phase IIa Data and New Drug Approval","url":"https://stock-news.laohu8.com/highlight/detail?id=1132266264","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1132266264?lang=en_us&edition=fundamental","pubTime":"2026-09-07 10:40","pubTimestamp":1788748818,"startTime":"0","endTime":"0","summary":"Tennor Therap-B (06872) shares jumped more than 15% in early trading, following a series of positive announcements. As of the time of writing, the stock was up 4.46% to HK$175.5 with a turnover of...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["VXUS","BK4588","06872","BK4585","BK1161","KCAI"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665360485","title":"Tennor Therapeutics Wins China NMPA Clearance for TNP-2092 Phase IIb PJI Trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2665360485","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665360485?lang=en_us&edition=fundamental","pubTime":"2026-09-07 08:03","pubTimestamp":1788739421,"startTime":"0","endTime":"0","summary":"Tennor Therapeutics wins China NMPA clearance for TNP-2092 phase IIb PJI trialTennor Therapeutics received China NMPA clearance to launch a multicenter Phase IIb trial of TNP-2092 for prosthetic joint","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260907:nNDL4YmzH0:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["06872","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1187574878","title":"TenNor Therapeutics Shows Stable Share Structure in August 2026 Filing","url":"https://stock-news.laohu8.com/highlight/detail?id=1187574878","media":"Bulletin Express","labels":["SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1187574878?lang=en_us&edition=fundamental","pubTime":"2026-09-02 17:02","pubTimestamp":1788339721,"startTime":"0","endTime":"0","summary":"TenNor Therapeutics (Suzhou) Limited released its monthly return for the period ended 31 August 2026, confirming that both authorised and issued share capital remained unchanged throughout the month....","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["06872"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662179905","title":"TenNor Therapeutics 1H FY26 Loss Narrows 17.81% to RMB 64.25 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2662179905","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662179905?lang=en_us&edition=fundamental","pubTime":"2026-08-26 17:05","pubTimestamp":1787735125,"startTime":"0","endTime":"0","summary":"TenNor Therapeutics 1H FY26 loss narrows 17.81% to RMB 64.25 millionTenNor Therapeutics posted a net loss of RMB 64.25 million for the six months ended June 30, narrowing from RMB 78.17 million.R&D ex","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260826:nNDL7S6B2d:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["06872","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1124008540","title":"Danuo Pharma-B Added to Hang Seng Composite Index, Paving Way for Stock Connect Inclusion","url":"https://stock-news.laohu8.com/highlight/detail?id=1124008540","media":"Stock News","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1124008540?lang=en_us&edition=fundamental","pubTime":"2026-08-21 18:54","pubTimestamp":1787309665,"startTime":"0","endTime":"0","summary":"On August 21, 2026, Hang Seng Indexes Company unveiled the results of its quarterly index review as of June 30, 2026, with Tennor Therap-B (06872) being added to the Hang Seng Composite Index. The...","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["FLHK","HSCI","06872","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659211486","title":"TenNor Therapeutics Schedules Board Meeting to Review Interim Results, Consider Dividend","url":"https://stock-news.laohu8.com/highlight/detail?id=2659211486","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659211486?lang=en_us&edition=fundamental","pubTime":"2026-08-14 16:33","pubTimestamp":1786696416,"startTime":"0","endTime":"0","summary":"TenNor Therapeutics schedules board meeting to review interim results, consider dividendTennor Therapeutics will hold a board meeting on Aug. 26, 2026 to review interim results for the six months ende","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260814:nNDL3mWNht:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1161","06872"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1121790734","title":"TenNor Therapeutics Reports Stable Share Base and Confirms Public Float Compliance for June 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=1121790734","media":"Bulletin Express","labels":["shareholding","SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1121790734?lang=en_us&edition=fundamental","pubTime":"2026-07-03 14:09","pubTimestamp":1783058961,"startTime":"0","endTime":"0","summary":"TenNor Therapeutics (Suzhou) Limited released its Monthly Return for Equity Issuer for the period ended 30 June 2026, indicating no changes in share capital structure during the month. The company’s...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["06872"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1162988284","title":"TenNor Therapeutics secures 100% shareholder backing for all six AGM resolutions","url":"https://stock-news.laohu8.com/highlight/detail?id=1162988284","media":"Bulletin Express","labels":["shareholding","SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1162988284?lang=en_us&edition=fundamental","pubTime":"2026-06-29 20:23","pubTimestamp":1782735792,"startTime":"0","endTime":"0","summary":"TenNor Therapeutics (Suzhou) Limited recorded unanimous shareholder support for every motion tabled at its 2025 annual shareholders’ meeting (ASM) held on 29 June 2026 in Suzhou, Jiangsu. The...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["06872"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2647379768","title":"Tennor Therapeutics Holds Annual Shareholders’ Meeting","url":"https://stock-news.laohu8.com/highlight/detail?id=2647379768","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2647379768?lang=en_us&edition=fundamental","pubTime":"2026-06-29 20:08","pubTimestamp":1782734912,"startTime":"0","endTime":"0","summary":"TenNor Therapeutics holds annual shareholders’ meetingTennor Therapeutics (Suzhou) held its 2025 annual shareholders’ meeting on June 29, 2026.Shareholders adopted the 2025 board work report.The 2025 ","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260629:nNDL5Nkxmz:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["06872","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1160842277","title":"TenNor Therapeutics issues notice for 2025 Annual Shareholders’ Meeting","url":"https://stock-news.laohu8.com/highlight/detail?id=1160842277","media":"Bulletin Express","labels":["SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1160842277?lang=en_us&edition=fundamental","pubTime":"2026-06-08 22:43","pubTimestamp":1780929800,"startTime":"0","endTime":"0","summary":"TenNor Therapeutics (Suzhou) Limited has announced that its 2025 Annual Shareholders’ Meeting (ASM) will be convened on Monday, 29 June 2026, at 2:00 p.m. The session will take place at Unit 701,...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["06872"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1149845710","title":"TenNor Therapeutics Releases Proxy Details for 29 June 2026 Annual Shareholders’ Meeting","url":"https://stock-news.laohu8.com/highlight/detail?id=1149845710","media":"Bulletin Express","labels":["SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1149845710?lang=en_us&edition=fundamental","pubTime":"2026-06-08 22:43","pubTimestamp":1780929799,"startTime":"0","endTime":"0","summary":"TenNor Therapeutics (Suzhou) Limited has distributed a proxy form for its 2025 annual shareholders’ meeting, scheduled for 2:00 p.m. on 29 June 2026 at Unit 701, Block B7, BioBay, 218 Xinghu Street,...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["06872"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2641480577","title":"TenNor Therapeutics announces annual shareholders meeting","url":"https://stock-news.laohu8.com/highlight/detail?id=2641480577","media":"Reuters","labels":["event"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2641480577?lang=en_us&edition=fundamental","pubTime":"2026-06-08 22:26","pubTimestamp":1780928794,"startTime":"0","endTime":"0","summary":"TenNor Therapeutics will hold its 2025 annual shareholders’ meeting in Suzhou, China on June 29, 2026.Shareholders will vote on the 2025 board work report, the independent non-executive directors’ performance report, the annual financial report.Other items include the 2025 profit distribution plan, directors’ remuneration plan, appointment of the 2026 auditor.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Tennor Therapeutics  Ltd. published the original content used to generate this news brief via IIS, the regulatory disclosure system operated by the Hong Kong Stock Exchange  , on June 08, 2026, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260608:nNDL1hNGMQ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"event","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["06872"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1114015599","title":"TenNor Therapeutics to Withhold 2025 Dividends and Re-Appoint PwC as 2026 Auditor","url":"https://stock-news.laohu8.com/highlight/detail?id=1114015599","media":"Bulletin Express","labels":["SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1114015599?lang=en_us&edition=fundamental","pubTime":"2026-06-08 22:23","pubTimestamp":1780928592,"startTime":"0","endTime":"0","summary":"TenNor Therapeutics (Suzhou) Limited will convene its 2025 Annual Shareholders’ Meeting (ASM) on 29 June 2026 at its Suzhou headquarters to vote on six ordinary resolutions covering operational,...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["06872"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1164030099","title":"TenNor Therapeutics Publishes Revised Articles, Detailing Share Capital, Governance Structure and Dividend Policy","url":"https://stock-news.laohu8.com/highlight/detail?id=1164030099","media":"Bulletin Express","labels":["SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1164030099?lang=en_us&edition=fundamental","pubTime":"2026-06-08 22:23","pubTimestamp":1780928590,"startTime":"0","endTime":"0","summary":"TenNor Therapeutics (Suzhou) Limited (“TenNor Therapeutics”) has released its updated Articles of Association as it prepares for trading on the Main Board of The Stock Exchange of Hong Kong (HKEX)...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["06872"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1198572504","title":"TenNor Therapeutics amends Articles post-IPO, skips FY2025 dividend, reshuffles remuneration committee","url":"https://stock-news.laohu8.com/highlight/detail?id=1198572504","media":"Bulletin Express","labels":["SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1198572504?lang=en_us&edition=fundamental","pubTime":"2026-06-08 22:23","pubTimestamp":1780928586,"startTime":"0","endTime":"0","summary":"TenNor Therapeutics (Suzhou) Limited announced three board resolutions on 8 June 2026: 1. Articles of Association updated after H-share listing   • The company finalised its Articles of Association...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["06872"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2641480891","title":"TenNor Therapeutics files list of directors with Hong Kong Stock Exchange","url":"https://stock-news.laohu8.com/highlight/detail?id=2641480891","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2641480891?lang=en_us&edition=fundamental","pubTime":"2026-06-08 22:17","pubTimestamp":1780928276,"startTime":"0","endTime":"0","summary":"Tennor Therapeutics  filed an updated list of directors with the Hong Kong Stock Exchange dated June 8, 2026.Board composition: 1 executive director, 1 non-executive director, 3 independent non-executive directors.Executive director: Ma Zhenkun; non-executive director: Song Gaoguang.Independent directors: Lee Wai Kong, Albert; Ni Lin; Li Leping.Committee chairs: Ma , Lee , Li .Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Tennor Therapeutics  Ltd. published the original content used to generate this news brief via IIS, the regulatory disclosure system operated by the Hong Kong Stock Exchange  , on June 08, 2026, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260608:nNDL63x6bg:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["06872"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1130046475","title":"TENNOR THERAP-B Appoints Dr. Song Gaoguang to Compensation and Assessment Committee","url":"https://stock-news.laohu8.com/highlight/detail?id=1130046475","media":"Stock News","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1130046475?lang=en_us&edition=fundamental","pubTime":"2026-06-08 22:16","pubTimestamp":1780928215,"startTime":"0","endTime":"0","summary":"TENNOR THERAP-B (ASX: 06872) has announced the appointment of Dr. Song Gaoguang, a non-executive director, to the board's Compensation and Assessment Committee.His term on the committee is effective from June 8, 2026, and will continue until the conclusion of the current board's inaugural term.","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["06872"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2641487161","title":"TenNor Therapeutics issues shareholder letter on electronic dissemination of corporate communications","url":"https://stock-news.laohu8.com/highlight/detail?id=2641487161","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2641487161?lang=en_us&edition=fundamental","pubTime":"2026-06-08 21:56","pubTimestamp":1780926989,"startTime":"0","endTime":"0","summary":"TenNor Therapeutics  outlined a shift to electronic dissemination of future corporate communications under Hong Kong Listing Rule 2.07A.Actionable corporate communications will be sent to shareholders by email; printed copies will be used when no functional email address is on file.No publication notices will be issued for website-posted corporate communications; shareholders are expected to monitor the sites directly.Shareholders can request printed communications; print-election preferences lapse at the earlier of revocation or each financial year-end.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Tennor Therapeutics  Ltd. published the original content used to generate this news brief via IIS, the regulatory disclosure system opera","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260608:nNDLmHRx2:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["06872"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":3,"pageCount":1,"totalSize":48,"code":"91000000","status":"200"}]}}